Evidence map›Paper›PMID 42819061›Full record

ArticleFrontiers in cellular and infection microbiology2026

HIV-1 interactions with sialic acid-binding bacterial lectins promote virus infectivity

Clauvis Kunkeng Yengo, Xiaomei Liu, Ries J Langley, Frida Avila, Manish Sagar, Christina Ochsenbauer, Barbara A Bensing, Catarina E Hioe

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Clauvis Kunkeng YengoDivision of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Xiaomei LiuDivision of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Ries J LangleyMolecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
Frida AvilaDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Manish SagarDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Christina OchsenbauerDepartment of Medicine, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Barbara A BensingDepartment of Medicine, San Francisco Veterans Affairs Medical Center and University of California, San Francisco, San Francisco, CA, United States.
Catarina E HioeDivision of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
Using immune complex vaccines to optimize antibody responses to HIV EnvR01AI148327 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HIOE, CATARINA E · 2020 to 2025
$4.5M
Harnessing Abs specific for immunogenic and conserved Env epitopes to protect against HIVR01AI139290 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HIOE, CATARINA E · 2018 to 2022
$4.1M
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmissionR01AI172843 · NIAID · BOSTON MEDICAL CENTER · PI SAGAR, MANISH · 2022 to 2025
$3.5M
Biologic consequences of HIV-1 interaction with bacteriaR21AI150909 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HIOE, CATARINA E · 2020 to 2021
$501k
Using streptococcal sialoglycan binding proteins to characterize MUC7 glycoformsR03DE029516 · NIDCR · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI BENSING, BARBARA ANNE · 2020 to 2021
$307k
BLRD VA I01 BX005616BLRD VA IK6 BX004607NIAID NIH HHS P30 AI042853NIAID NIH HHS R01 AI139290NIAID NIH HHS R01 AI148327NIAID NIH HHS R01 AI172843NIAID NIH HHS R21 AI150909NIDCR NIH HHS R03 DE029516
6 · The paper itself

Abstract

Most human immunodeficiency virus type 1 (HIV-1) transmission occurs at mucosal surfaces, which are colonized by the host microbiota. However, interactions between HIV and bacteria or bacterial products derived from the human microbiome are poorly characterized, and their biological consequences are largely unexplored. Here, we evaluated the effects of sialic acid-binding lectins expressed by bacterial species ubiquitous in the human microbiota on HIV-1 infectivity using viruses produced in 293T cells and human primary cells. We demonstrated that these bacterial lectins enhanced HIV-1 infectivity in a sialoglycan-dependent manner. Specifically, Siglec-like binding region lectins (SLBR-N, SLBR-H, and SLBR-B) from

Indexed as

HIV-1HIV InfectionsLectinsMucous MembraneSialic Acid Binding Immunoglobulin-like LectinsAnimalsCD4-Positive T-LymphocytesDisease Models, AnimalHEK293 CellsHumansMiceN-Acetylneuraminic AcidStaphylococcus aureusStreptococcus gordoniiVirus AttachmentLectinsN-Acetylneuraminic AcidSialic Acid Binding Immunoglobulin-like Lectinsbacterial lectinsHIV-1mucosal transmissionsialoglycantrans-infection

Identifiers

PMID42819061
PMCPMC13623568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.